samedan logo
 
 
spacer
home > ict > spring 2017 > turn of phrase
PUBLICATIONS
International Clinical Trials

Turn of Phrase

Over the past 10 years, the market value of the global pharmaceutical industry has more than doubled to $951 billion. In 2015, markets outside the US and Western Europe accounted for $362 billion, comprising approximately 38% of the total worldwide value (1).

There is no doubt about it: the healthcare industry has become truly global, and clinical trials are being delocalised to match. In fact, between 2005 and 2012, the largest annual growth in clinical trials occurred in Asian (30%) and Latin American/Caribbean (12%) regions (2).

As the clinical trials industry expands into emerging countries, protocols developed in one country are increasingly implemented in culturally and linguistically different locations. Competent and compliant translation is, therefore, becoming more necessary than ever in order to ensure that clinical trial protocols (CPTs) are correctly followed, and that participants can confidently understand and consent to them.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Alicia Lewis is a Brighton-based Writer and Content Specialist for full-service clinical trials agency MD Group. On the company’s website, she comments on the latest biotechnological innovations and creates guides to patientcentric clinical trial protocols. Since 2014, Alicia has been writing content for businesses in the UK and abroad, specialising in healthcare, business, travel and culture.
spacer
Alicia Lewis
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Merck Expands Excipients Portfolio, Adding Polymers for Sustained Release Injectables


More info >>

White Papers

The Impact of Components on Drug Quality and Risk Mitigation

West Pharmaceutical Services, Inc.

Expectations for quality by regulatory agencies are increasing at a very fast pace, especially for prefilled drug delivery formats, thanks to increased focus on reducing risk to patient safety. The trend has resulted in delays for new drug applications, more recalls of marketed products and even drug shortages if the container system and drug contents are suspect for quality issues. The pharmaceutical market is now requiring manufacturers of containers and components to meet new expectations with a quality culture and very high product reliability. The need to bridge the gap and provide superior quality products has been a driver for manufacturing technology investments, more robust control strategies and the introduction of next generation elastomer components.
More info >>

 
Industry Events

DIA 2017 Annual Meeting

18-22 June 2017, Chicago, IL

Themed “Driving Insights to Action,” DIA 2017 will host 8,000+ professionals in the pharmaceutical, biotechnology, and medical device communities from more than 50 countries. DIA 2017 boasts more than 450 exhibiting companies, 10+ tracks, and 160+ sessions focused on regulatory science, translational medicine, patient engagement, and value and access. Follow DIA 2017 updates on Twitter using #DIA2017.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement